Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia.
Journal Information
Full Title: Br J Haematol
Abbreviation: Br J Haematol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"CONFLICT OF INTEREST The authors do not have any conflict of interest to declare."
"We thank the physicians caring for the patients, the technicians of the haemostasis laboratory, Prof. MD Michel Duchosal for support, and Prof. MD Pierre‐Alexandre Bart for acting as expert of the MD thesis of Matteo Marchetti. This study has been partially presented at the Swiss Oncology and Haematology Congress (SOHC) in Zürich, Switzerland, June 2019. Open Access Funding provided by Universite de Lausanne. [Correction added on 26 May 2022, after first online publication: CSAL funding statement has been added.]"
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025